Aim. To characterize acquired chronic obstructive pulmonary diseases (COPD)
in patients with ischemic heart disease (IHD).
Material and methods. Monitoring of external respiration function (ERF) was
performed for 15 years in 1552 IHD patients on combined drug treatment.
Results. The 15-year follow-up has revealed that IHD patients treated with
beta-blockers develop pathological changes in respiration pattern manifesti
ng primarily with dyspnea, obstructive and mixed ventilatory disorders, syn
drome of early expiratory obstruction in affected small airways due to subn
ormal lung elasticity, defective diffuse function, signs of terminal respir
atory failure.
Conclusion. IHD patients taking drugs need monitoring of ERF Optimal treatm
ent consists in early diagnosis of IHD and COPD, adequate combined therapy
with beta-blockers and bronchodilating drugs.